Everest Organics Limited (BOM:524790)
258.10
+0.30 (0.12%)
At close: Jun 16, 2026
Everest Organics Revenue
In the fiscal year ending March 31, 2026, Everest Organics had annual revenue of 1.97B INR with 23.41% growth. Everest Organics had revenue of 489.08M in the quarter ending March 31, 2026, with 19.47% growth.
Revenue
1.97B
Revenue Growth
+23.41%
P/S Ratio
1.27
Revenue / Employee
5.56M
Employees
355
Market Cap
2.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.97B | 374.51M | 23.41% |
| Mar 31, 2025 | 1.60B | -380.70M | -19.23% |
| Mar 31, 2024 | 1.98B | 141.55M | 7.70% |
| Mar 31, 2023 | 1.84B | -177.25M | -8.79% |
| Mar 31, 2022 | 2.02B | 195.19M | 10.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.02B |
| Medicamen Biotech | 2.01B |
| Sat Kartar Life | 2.01B |
| Gennex Laboratories | 1.73B |
| Kerala Ayurveda | 1.31B |
| Trident Lifeline | 1.29B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |